Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer

FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer

Childhood obesity raises bladder cancer risk, study looking at 315,000 children suggests

Childhood obesity raises bladder cancer risk, study looking at 315,000 children suggests

New LAT1 inhibitor can boost cancer treatment

New LAT1 inhibitor can boost cancer treatment

FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer

FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer

Researchers develop model to predict prostate cancer aggressiveness

Researchers develop model to predict prostate cancer aggressiveness

Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer

Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer

ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer

ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration...

A combo of fasting plus vitamin C is effective for hard-to-treat cancers

A combo of fasting plus vitamin C is effective for hard-to-treat cancers

Novel radiotracer meets gold standard for imaging prostate cancer

Novel radiotracer meets gold standard for imaging prostate cancer

New therapeutic targets for infertility and cancer revealed

New therapeutic targets for infertility and cancer revealed

More from ecancer